爱发朋友圈让你更长寿?社交网络发达是利是弊

2019-12-04 dingka MedSci原创

群居动物社交由线下转为线上,是是非非仍需辩证看待。

不论是微信、抖音、还是微博,社交媒体作为现代人生活的一部分,已经扮演了越来越重要的角色,我们在这些App上花费的时间也越来越多。那么,社交媒体会对我们产生什么样的影响呢?




嘿,爱发朋友圈的人更长寿!


一项发表在PNAS的研究表明,在社交媒体上活跃的人,其寿命更长1



之前网络还没有这么发达,大部分人都是在现实生活中进行社交活动。而早有现象表明,与更多朋友交流、社会关系更多的人,其寿命更长。

那么,在大家早已转到线上社交的今天,该类行为对我们的寿命和健康有啥影响呢?

从下图数据我们可以看出,“接受好友申请”的数量与降低死亡率之间存在相关性。


该图描述了作者所提出的“在线社交活跃度与寿命之间的关系”。其中左图反映的是Facebook账户“发出好友申请并被接受”的数量与死亡率之间的关系;右图反映的则是“接受他人发出的好友申请”的数量与死亡率之间的关系。

原来,线上社交也有同样的效果。产生这一联系是纯属偶然,还是背后有什么更深层次的原因?

进一步,作者分析了人们的各种死因,包括癌症、心血管疾病、自杀以及药物滥用等。

结果表明,除癌症外,其它死亡风险随Facebook好友数量与接受好友数量增加而降低。除此之外,上传照片的次数升高与除自杀外的其他所有主要原因的死亡率降低相关。


(此时突然就想到了有事没有都要发票圈的自己,感觉又能多活好几年了呢!)

对此,作者认为线上社交活动能够满足人们作为“群居动物”的基本需求,因此有益于整体的身心健康。



这项研究提出了一个非常有意思的假设,那就是线上社交媒体或许能够起到与线下社交活动一样的积极效果。

毕竟不论线上线下,跟人聊天总会让人心情舒畅,减少压力的同时也会降低各类疾病的发生风险。


社交媒体导致青少年抑郁


然而,并不是所有人都认可社交媒体的积极作用。

发票圈,是自己单方面输出。但是,如果发出去10分钟内还是没有人点赞留言互动,可能就会产生怀疑诸如「没人喜欢?不能够啊?网不好吗?」等等之类的想法。

例如,近日Instagram改变界面风格,使用户帖子被“点赞”的数值不被公开显示。对此,心理健康专家们认为这会减轻人们使用社交媒体时产生的心理困扰2




许多人认为,这可能有助于消除用户的紧张感。尤其是在年轻用户中,Instagram帖子被“点赞”的数量往往是体现自我价值的指标。

一些年轻的Instagram用户表示,当自己的帖子没有收到很多“赞”时,他们会感到挫败,以及认为自己不受欢迎。

2017年,芝加哥大学与美联社合作的一项调查显示,在790名13至17岁的美国青少年中,有78%的人称社交媒体使他们与朋友更亲近,有49%的人称社交媒体使他们与朋友更亲密,并且42%的人表示这有助于他们与家人联系3

但是,社交媒体的使用也会使年轻人感到“不足”和“不值得”。

在同一项调查中,有15%的受访者表示感到压力,因为需要时刻展现完美的自己。10%的受访者报告信息太多看不过来,另有9%的受访者表示感到不知所措或害怕错过关键的信息。调查还显示,有58%的青少年已经至少卸载了一个社交App。



此外,其它研究也将青年时期使用社交媒体与心理健康的恶化(包括抑郁症和焦虑症)联系起来。

究其原因,许多人认为是由于社交媒体使年轻人感到更加“孤立”。据调查,青少年群体自杀率在过去30年中增加了30%,国家心理健康研究所的数据也显示,自杀现在是10至34岁人群中第二大死亡原因。因此,在保护青少年的心理健康方面,社交媒体的重要性不可忽视。

看到这里,大家一定会感到困惑,社交媒体到底对我们是有益还是有害呢?

小编认为,看待事情往往需要用辩证的眼光。我们需要重视社交媒体在日常生活中的意义,并且好好利用其价值,维系与亲人朋友们的联系;另一方面,我们还是要对现实世界有足够的重视。

“社交平台”仅仅是工具,其背后的人才是我们真正想要连接的目标。

因此,与其在“朋友圈”晒照片集赞,不妨抽时间找亲朋好友聚一聚吧!





参考文献:
1. Hobbs, William R., Moira Burke, Nicholas A. Christakis, and James H. Fowler. Online Social Integration is Associated with Reduced Mortality Risk. PNAS. 2016, 113(46): 12980–984.
2. Killing Instagram Likes: Will It Really Improve Users' Mental Health? Medscape Medical News.
3. American teens are taking breaks from social media. The Associated Press-Norc Center for Public Affairs Research
来源:梅斯医学

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-06 fengyi818
  4. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-05 15938038573红旗飘飘

    转发一下,长寿一次

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-04 lovetcm

    转发一下,长寿一次

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-04 14794e5bm67(暂无昵称)

    研究结果令人兴奋

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-04 14794e5bm67(暂无昵称)

    研究结果令人兴奋

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-04 14794e5bm67(暂无昵称)

    研究结果令人兴奋

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-04 14794e5bm67(暂无昵称)

    研究结果令人兴奋

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1983366, encodeId=7bab1983366e3, content=<a href='/topic/show?id=f3abe392977' target=_blank style='color:#2F92EE;'>#社交网络#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73929, encryptionId=f3abe392977, topicName=社交网络)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Mon Jul 20 19:43:00 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670938, encodeId=3fd516e093873, content=<a href='/topic/show?id=92bf60e12b4' target=_blank style='color:#2F92EE;'>#朋友圈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60712, encryptionId=92bf60e12b4, topicName=朋友圈)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Wed Sep 30 06:43:00 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603441, encodeId=141016034410b, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Fri Dec 06 00:43:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376562, encodeId=70613e6562a5, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Thu Dec 05 06:41:24 CST 2019, time=2019-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376552, encodeId=71ef3e6552a9, content=转发一下,长寿一次, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Dec 04 20:47:56 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376541, encodeId=25183e654135, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:24 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376540, encodeId=93a33e65400f, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:20 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376539, encodeId=ae2d3e65394c, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:16 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376538, encodeId=f44e3e653832, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:10 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376537, encodeId=6ced3e653728, content=研究结果令人兴奋, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b005228115, createdName=14794e5bm67(暂无昵称), createdTime=Wed Dec 04 16:02:07 CST 2019, time=2019-12-04, status=1, ipAttribution=)]
    2019-12-04 14794e5bm67(暂无昵称)

    研究结果令人兴奋

    0

相关资讯

惊艳!平时一号难求的华西医院“大牛”,组乐队唱RAP刷遍朋友圈

手术刀换成麦克风、听诊器变成五线谱,抱起吉他贝斯、敲起架子鼓,你还认得出,他们其实是穿着白大褂、救死扶伤的医生吗?最近,四川大学华西医院艺术节活动之一的健康音乐大赛决赛前,曝光了26首原创歌曲,刷爆了朋友圈。大家惊呼,平时一本正经、一号难求的专家医生们,其实都是被医学事业耽误的歌手。你见过医疗界大牛的老专家拗造型、摆自拍吗?听过椒盐RAP教你营养学吗?当下最流行的嘻哈风、摇滚风、中国风教你防晒、让

学医的都进来,朋友们是这样吐槽你们的!

在很多人心目中,学医的人是这样的1.我的朋友。我们都是学医的,他和别人玩撕名牌,不小心摔倒了,作为医学生,他敏锐地感觉到自己骨折了。作为医学精英,他体内的某个小宇宙爆发了,遂尝试了一下手法复位。于是在场的同学都听到了一声声嘶力竭的嚎叫。去医院拍片子,粉碎性骨折。2.一起去蹦极,他给我解释如果我掉下来,骨头会碎成什么样。3.聊天工具上大半夜一个猥琐男问我要裸照,二话没说给他发了一堆尸体的裸照。4.把

医生个人如何塑造微信朋友圈的影响力?

朋友圈个人品牌积累和线下医院、诊所是相辅相成的,患者信任你才会去就诊,经过临床治疗和修复以后就更信任你。如果你有5000位粉丝,你辞职开一个诊所,肯定很赚钱。现在越来越多的医生开始注意个人品牌的塑造。而塑造品牌的第一步是微信朋友圈。微信朋友圈到底应该怎么做呢?  一、道    在营销中,这个“道”就是你用来支配自己行为的思维体系,当你营销的思维体系完善,你的所有营销行为都是在你的全局思维

2016刷爆朋友圈的“医护网红”故事,看看你知道几个?

2016年即将过去,还有二十几天我们将要迎来崭新的2017年。今年,我们医护人员中有许多温情感动美好的故事刷爆了朋友圈,下面跟小编一起回顾一下那些温暖瞬间吧,看看最打动你的是哪位“医护网红”。1 上央视新闻的奥运随队医生--胡智宏 江苏省人民医院传统康复科主任胡智宏医生今年参加了里约奥运会,他是江苏唯一跟队飞赴里约的医务保障成员。为了备战奥运会,前期他在北京参加了一系列培训,国家队出

**拍出11万一颗,朋友圈“神药”安宫牛黄丸是什么来头?

近日,在微信朋友圈中,一款“神药”又火了。一粒拍出11万元天价,号称能有病治病无病防病,这款“神药”就是安宫牛黄丸。但所谓对症下药,什么样的症状用什么样的药,包治百病的“神药”从何而来,真有这么神?医生说,该药是一款紧急用药,并不是包治百病的神药。至于药价之高,有原材料的原因,也不排除炒作的可能。一颗上世纪60年代的安宫牛黄丸,以11万元的天价拍卖成交,一颗1993年的安宫牛黄丸也被炒到上万元。预